IGFBP7 exhibits a dual role in cancer, exerting antitumor effects by inhibiting tumor cell growth and accelerating apoptosis, while also inducing a disordered tumor vasculature system by binding to CD93 [58,63]. Here, CD93 is linked to cancer.